FDA to Revamp Approval Path for OTC Drugs

FDA to Revamp Approval Path for OTC Drugs

These include improving the FDA's ability to quickly require new warnings or label changes as safety issues emerge based on new science. In addition, the agency said it hopes to allow innovative changes in products more quickly. It also wants to

8
Like
Save

Comments

Write a comment

*